- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04722965
Treatment of Lower Transsphincteric Perianal Fistula: Fistulotomy With Marsupialization vs Open Wound
March 18, 2024 updated by: Consorci Sanitari de l'Alt Penedès i Garraf
Randomized Clinical Trial for the Treatment of Lower Transsphincteric Perianal Fistula Using Fistulotomy With Marsupialization vs Open Wound
This study will compare the results of marsupialization versus open wound after fistulotomy in low transsphincteric perianal fistulas.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
This is a multi-center triple blinded randomized clinical trial in which we'll compare two techniques for the treatment of simple low transsphincteric perianal fistulas.
40 patients will undergo a fistulotomy with marsupialization and 40 patients will undergo a fistulotomy with open wound.
There will be an inclussion visit in which personal information will be recorded and the consent will be signed.
Randomization will be done after inclusion, following a balanced blocks model.
Information of the surgery technic won't be available for the investigator.
The patients will have a journal in which they'll write their postoperative symptoms.
Follow up will be done at weeks 2, 4 and 6 by the main investigator of each center.
Data will be based in clinical examination, patient's diary and medical records.
Statistical analysis of the primary outcome will be based in a superiority analysis using the Mantel-Cox test, or in case needed, a multivariate Cox regression analysis.
The secondary outcomes will be analyzed by comparing times, percentages, mean or median with parametric or non parametric tests as it corresponds.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Barcelona
-
Sant Pere De Ribes, Barcelona, Spain, 08810
- Consorci Sanitari Alt Penedes i Garraf
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Low transsphinteric perianal fistula, defined as a single tract in the lower third of the anal sphincter, confirmed by ultrasound and intraoperative evaluation.
- Ability to understand the study, to sign the consent and to complete the follow-up.
Exclusion Criteria:
- Under 18 years of age.
- Complex/recurrent fistula.
- Patients in which by clinical criteria is decided not to perform a fistulotomy.
- Anorectal malignancy.
- Crohn's desease.
- ASA IV or other contraindication for surgery.
- Inmunosuppressed patients or in treatment with steroids or cytotoxic drugs.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Fistulotomy with marsupialization
40 patients with a simple low transsphincteric anal fistula.
A fistulotomy with marsupialization is performed.
|
A probe is placed in the fistula tract and it's laid open over that probe.
The tract is curretted.
Wound edges are sutured to the bottom of the fistula using interrupted sutures of vicryl 3-0 completing the marsupialization.
|
|
Active Comparator: Fistulotomy with open wound
40 patients with a simple low transsphincteric anal fistula.
A fistulotomy leaving the wound open is performed.
|
A probe is placed in the fistula tract and it's laid open over that probe.
The tract is curretted.
The wound is left open.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wound healing time
Time Frame: 6 weeks
|
Comparisson of the time it takes for the wound to not have areas without epithelium after the fistulotomy between the group with marsupialization and the open wound group.
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative pain
Time Frame: 6 weeks
|
Maximum pain experienced by the patient in the postoperative period measured by the visual scale of pain.
|
6 weeks
|
|
Return to daily activities
Time Frame: 6 weeks
|
Days it takes the patients to return their daily activities (e.g.
job).
|
6 weeks
|
|
Operating time
Time Frame: 60 minutes
|
Time the surgery takes since the assessment of the fistula tract to the beginning of dressing of the postoperative wound.
It's measured in minutes.
|
60 minutes
|
|
Hospitalization time
Time Frame: 2 days
|
Days the patient has to stay admitted in the hospital.
|
2 days
|
|
Anal incontinence
Time Frame: 6 weeks
|
Postoperative anal incontinence measured by the Browning and Parks incontinence scale: I: normal continence, II: Continent for solid and liquid stools but not for flatus, III: Continent for solid stools only, IV: Complete incontinence.
|
6 weeks
|
|
Frequency of dressing change
Time Frame: 6 weeks
|
Number of times per day a patient needs a dressing change
|
6 weeks
|
|
Who performs the dressing change
Time Frame: 6 weeks
|
Indicate who performs the dressing change: Patient, family member or medical professional.
|
6 weeks
|
|
Postoperative wound infection
Time Frame: 6 weeks
|
Presence of erythema, induration surrounding the wound or suppuration with or without an isolated pathogenic microorganism.
|
6 weeks
|
|
Recurrence of the fistula
Time Frame: 1 year
|
Reappearance of the fistula after complete healing of the surgical wound within the period of the study.
|
1 year
|
|
Bleeding of the postoperative wound
Time Frame: 6 weeks
|
Number of bleeding episodes that require more changing of the dressings or assistance of a medical professional.
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jessica Gonzales, MD, CSAPG
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2021
Primary Completion (Estimated)
February 1, 2023
Study Completion (Estimated)
July 1, 2023
Study Registration Dates
First Submitted
January 21, 2021
First Submitted That Met QC Criteria
January 21, 2021
First Posted (Actual)
January 25, 2021
Study Record Updates
Last Update Posted (Actual)
March 19, 2024
Last Update Submitted That Met QC Criteria
March 18, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CSAPG-13
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Perianal Fistula
-
William A. Faubion, M.D.CompletedPerianal Fistula | Cryptoglandular Perianal Fistula | Crohn's Perianal FistulaUnited States
-
Sohag UniversityNot yet recruiting
-
Alexandria UniversityNot yet recruiting
-
AHEPA University HospitalAristotle University Of ThessalonikiRecruitingPerianal Abscess | Perianal Crohn Disease | Perianal Fistula | Fistula in Ano | Pilonidal Cyst/Fistula | Anal Fissure and FistulaGreece
-
Angiocrine BioscienceNot yet recruitingCryptoglandular Perianal FistulaUnited States
-
TakedaTakeda Development Center Americas, Inc.TerminatedCrohn's Disease | Complex Perianal FistulaSpain, Israel, Netherlands, Japan, Poland
-
Mayo ClinicCompletedPerianal Fistula | Cryptoglandular Perianal FistulaUnited States
-
Tigenix S.A.U.Completed
-
Nordic Drugs ABCompletedPerianal FistulasSweden
-
Instituto de Investigación Hospital Universitario...UnknownExtremely Complex Perianal FistulaeSpain
Clinical Trials on Fistulotomy with marsupialization
-
Mansoura UniversityCompleted
-
Zagazig UniversityCompleted
-
Zagazig UniversityCompleted
-
Central Park Medical CollegeCompletedWound Healing | Fistula in Ano | Fistulectomy | Fistulectomy With MarsupializationPakistan
-
Kanuni Sultan Suleyman Training and Research HospitalCompleted
-
Islamabad Medical and Dental CollegeCompletedAnal Fistula | Perianal Fistula | Fistula-in-anoPakistan
-
Lawrence Charles HookeyCompletedBiliary Disease | ERCP | Biliary Disease TractCanada
-
Tehran University of Medical SciencesNot yet recruiting
-
Lawrence Charles HookeySuspendedBiliary Tract Diseases | Cholangiopancreatography, Endoscopic RetrogradeCanada